Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells

Cellular Immunology

Volumn 199, Issue 1, 2000, Pages 43-49

  Van Der Veen, Roel C ^a   Dietlin, Therese A ^a   Dixon Gray, J ^a   Gilmore, Wendy ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

EAE; Nitric oxide; Th1 Th2

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADOLESCENT; ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALIA;

EID: 0034627986     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.1999.1597     Document Type: Article

References (49)

1. Mokhtarian F., McFarlin D. E., Raine C. S. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature. 309:1984;356-358.
2. Zamvil S., Nelson P., Trotter J., Mitchell D., Knobler R., Fritz R., Steinman L. T cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature. 317:1985;355-358.
3. Lemire J. M., Weigle W. O. Myelin basic protein-specific T cell clones and experimental allergic encephalomyelitis. Path. Immunopath. Res. 5:1986;248-252.
4. van der Veen R. C., Trotter J. L., Hickey W. F., Kapp J. A. The development and characterization of encephalitogenic cloned T cells specific for myelin proteolipid protein. J. Neuroimmunol. 26:1990;139-145.
5. Gajewski T. F., Schell S. R., Nau G., Fitch F. W. Regulation of T-cell activation: Differences among T-cell subsets. Immunol. Rev. 111:1989;79-110.
6. Cher D. J., Mosmann T. R. Two types of murine helper T cell clone II. Delayed-type hypersensitivity is mediated by Th1 clones. J. Immunol. 138:1987;3688-3694.
7. Mosmann T. R., Coffman R. L. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
8. Fiorentino D. F., Mosmann T. R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
9. Cserr H. F., Knopf P. M. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: A new view. Immunol. Today. 13:1992;507-512.
10. Harling-Berg C. J., Knopf P. M., Cserr H. F. Myelin basic protein infused into cerebrospinal fluid suppresses experimental autoimmune encephalomyelitis. J. Neuroimmunol. 35:1991;45-51.
11. Langermans J. A. M., van der Hulst M. E. B., Nibbering P. H., Hiemstra P. S., Fransen L., van Furth R. IFN-γ-induced l-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α J. Immunol. 148:1992;568-574.
12. Imai T., Hirata Y., Kanno K., Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J. Clin. Invest. 93:1994;543-549.
13. 2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol. Chem. Hoppe-Seyler. 373:1992;897-902.
14. 2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. J. Immunol. 151:1993;2132-2141.
15. Ludowyk P. A., Hughes W., Hugh A., Willenborg D. O., Rockett K. A., Parish C. R. Astrocytic hypertrophy: An important pathological feature of chronic experimental autoimmune encephalitis in aged rats. J. Neuroimmunol. 48:1993;121-134.
16. Bagasra O., Michaels F. H., Zheng Y. M., Bobroski L. E., Spitsin S. V., Fu Z. F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;12041-12045.
17. Bo L., Dawson T. M., Wesselingh S., Mork S., Choi S., Kong P. A., Hanley D., Trapp B. D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
18. Cross A. H., Misko T. P., Lin R. F., Hickey W. F., Trotter J. L., Tilton R. G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
19. Zhao W., Tilton R. G., Corbett J. A., McDaniel M. L., Misko T. P., Williamson J. R., Cross A. H., Hickey W. F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:1996;123-133.
20. Hooper D. C., Ohnishi S. T., Kean R., Numagami Y., Dietzschold B., Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA. 92:1995;5312-5316.
21. Misko T. P., Trotter J. L., Cross A. H. Mediation of inflammation by encephalitogenic cells: Interferon γ induction of nitric oxide synthase and cyclooxygenase 2. J. Neuroimmunol. 61:1995;195-204.
22. Mitrovic B., Ignarro L. J., Montestruque S., Smoll A., Merrill J. E. Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cells in vitro. Neuroscience. 61:1994;575-585.
23. Zielasek J., Jung S., Gold R., Liew F. Y., Toyka K. V., Hartung H. P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.
24. Ruuls S. R., van der Linden S., Sontrop K., Huitinga I., Dijkstra C. D. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:1996;467-474.
25. Gold D. P., Schroder K., Powell H. C., Kelly C. J. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2863-2869.
26. Hogg, N., Kalyanaraman, B., and Darley-Usmar, V., Oxidant and antioxidant effects of nitric oxide and superoxide in the vasculature. InThe oxygen paradox (K. J. A. Davies and F. Ursini, Eds.), Cleup University Press, Padora, Italy, pp. 317-324.
27. Matthys P., Froyen G., Verdot L., Huang S., Sobis H., Van Damme J., Vray B., Aguet M., Billiau A. IFN-γ receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide. J. Immunol. 155:1995;3823-3829.
28. Kubes P., Kurose I., Granger D. N. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am. J. Physiol. 267:1994;931.
29. Mills C. D. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146:1991;2719-2723.
30. Tomioka H., Saito H. Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents. J. Leukocyte Biol. 51:1991;24-31.
31. Togashi H., Sasaki M., Frohman E., Taira E., Ratan R. R., Dawson T. M., Dawson V. L. Neuronal (type 1) nitric oxide synthase regulates nuclear NFkB activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. USA. 94:1997;2676-2680.
32. van der Veen R. C., Chen P.-J., McMillan M. Myelin proteolipid protein-induced Th1 and Th2 clones express TCR with similar fine specificity for peptide and CDR3 homology despite diverse Vβ usage. Cell. Immunol. 166:1995;291-295.
33. van der Veen R. C., Stohlman S. A. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: Relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:1993;213-220.
34. McCarthy K. D., deVellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell. Biol. 85:1980;890-902.
35. Gilmore W., Correale J., Weiner L. P. Coronavirus induction of Class I major histocompatibility complex expression in murine astrocytes is virus strain specific. J. Exp. Med. 180:1994;1013-1023.
36. van der Veen R. C., Hinton D. R., Incardonna F., Hofman F. M. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77:1997;1-7.
37. Taylor-Robinson A. W., Liew F. Y., Severn A., Xu D., McSorley S. J., Garside P., Padron J., Phillips R. S. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:1990;980-984.
38. Wei X.-Q., Charles I. G., Smith A., Ure J., Feng G.-J., Huang F.-P., Xu D., Muller W., Moncada S., Liew F. Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
39. Nukaya I., Takaji K., Kawabe T., Suketa T. Suppression of cytokine production in T helper type 2 cells by nitric oxide in comparison with T helper type 1 cells. Microbiol. Immunol. 39:1995;709-714.
40. Bauer H., Jung T., Tsikas D., Stichtenoth D. O., Frolich J. C., Neumann C. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology. 90:1997;205-211.
41. van der Veen R. C., Dietlin T. A., Pen L., Gray J. D. Nitric oxide inhibits the proliferation of T-helper 1 and 2 lymphocytes without reduction in cytokine secretion. Cell. Immunol. 193:1999;194-201.
42. Sahrbacher U. C., Lechner F., Eugster H. P., Frei K., Lassmann H., Fontana A. Mice with an inactivation of the inducible nitric oxide synthase gene are suspectible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;1332-1338.
43. Fenyk-Melody J. E., Garrison A. E., Brunnert S. R., Weidner J. R., Shen F., Shelton B. A., Mudgett J. S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:1998;2940-2946.
44. Radi R., Beckman J. S., Bush K. M., Freeman B. A. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288:1991;481-487.
45. Brito C., Naviliat M., Tiscornia A. C., Vuillier F., Gualco G., Dighiero G., Radi R., Cayota A. M. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J. Immunol. 162:1999;3356-3366.
46. Ding M., St. Pierre B. A., Parkinson J. F., Medberry P., Wong J. L., Rogers N. E., Ignarro L. J., Merrill J. E. Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia. A kinetic analysis. J. Biol. Chem. 272:1997;11327-11335.
47. 2) regulatory pathways. J. Immunol. 157:1996;2129-2135.
48. Eisenstein T. K., Huang D., Meissler J. J. Jr., al-Ramadi B. Macrophage nitric oxide mediates immunosuppression in infectious inflammation. Immunobiology. 191:1994;493-502.
49. Bukrinsky M. I., Nottet H. S., Schmidtmayerova H., Dubrovsky L., Flanagan C. R., Mullins M. E., Lipton S. A., Gendleman H. E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J. Exp. Med. 181:1995;735-745.